Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02123030
Official study title

A Micro/Nano Device for Exhaled Breath Analysis

Study summary

Use of a microfabricated silicon device to concentrate ultra trace volatile organic compounds (VOCs) in human exhaled breath for quantitative analysis of VOCs.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forLung Cancer · Pulmonary Disease

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 18, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Louisville

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Louisville
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • For controlled (healthy) subjects - we are seeking persons who do not have a known history of cancer or pulmonary disease.
  • Both smokers and nonsmokers are invited to participate as control subjects.
  • For experimental subjects, we are seeking persons with pulmonary disease but no known history of cancer, as identified by the investigators during routine clinic or office visits.
  • Additionally for experimental subjects, we are seeking persons with known or suspected lung or other cancers, as identified by the investigators during routine clinic or office visits.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • James Graham Brown Cancer Center-University of LouisvilleLouisville, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 18, 2021. Always confirm current availability with the study team.

View original record ↗